Allogene Therapeutics (ALLO) Prepaid Assets (2018 - 2026)

Allogene Therapeutics (ALLO) has 9 years of Prepaid Assets data on file, last reported at $6.4 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 44.45% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (down 44.45% YoY), and the FY2025 full-year result was $7.5 million, down 30.9% from the prior year.
• Prepaid Assets retreated to $6.4 million in Q1 2026, from $7.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $22.5 million in Q2 2022 to a low of $6.4 million in Q1 2026.
• A 5-year average of $11.8 million and a median of $10.5 million in 2024 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets slumped 55.01% in 2023 and surged 61.67% in 2024, its largest moves.
• Tracing ALLO's Prepaid Assets over 5 years: stood at $11.5 million in 2022, then retreated by 9.44% to $10.4 million in 2023, then rose by 4.72% to $10.9 million in 2024, then sank by 30.9% to $7.5 million in 2025, then declined by 15.02% to $6.4 million in 2026.
• Business Quant data shows ALLO's Prepaid Assets at $6.4 million in Q1 2026, $7.5 million in Q4 2025, and $8.5 million in Q3 2025.